Targeting Super‐Enhancers via Nanoparticle‐Facilitated BRD4 and CDK7 Inhibitors Synergistically Suppresses Pancreatic Ductal Adenocarcinoma

Combretastatin A4 Nanodrug‐Induced MMP9 Amplification Boosts Tumor‐Selective Release of Doxorubicin Prodrug

(2019) Jian Jiang et al.   ADVANCED MATERIALS

Third generation EGFR TKIs: current data and future directions

(2018) Chee-Seng Tan et al.   Molecular Cancer

Significant Suppression of Non-small-cell Lung Cancer by Hydrophobic Poly(ester amide) Nanoparticles with High Docetaxel Loading

(2018) Xing Chen et al.   Frontiers in Pharmacology

CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

(2017) Marianne Sinn et al.   JOURNAL OF CLINICAL ONCOLOGY

Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling

(2017) D J Junk et al.   ONCOGENE

Lysosomes as Oxidative Targets for Cancer Therapy

(2017) Rebecca F. Dielschneider et al.   Oxidative Medicine and Cellular Longevity

Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems

(2016) Mahdi Karimi et al.   CHEMICAL SOCIETY REVIEWS

Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma

(2016) Yan-Yi Jiang et al.   GUT

Strategies to Improve Outcomes of Patients with EGFR-Mutant Non–Small Cell Lung Cancer: Review of the Literature

(2016) Caicun Zhou et al.   Journal of Thoracic Oncology

Genomic analyses identify molecular subtypes of pancreatic cancer

(2016) Peter Bailey et al.   NATURE

Bioresponsive materials

(2016) Yue Lu et al.   Nature Reviews Materials

Whole genomes redefine the mutational landscape of pancreatic cancer

(2015) Nicola Waddell et al.   NATURE

BRD4 promotes pancreatic ductal adenocarcinoma cell proliferation and enhances gemcitabine resistance

(2015) YONG-HUI WANG et al.   ONCOLOGY REPORTS

EGFR and NF-κB: partners in cancer

(2015) Kateryna Shostak et al.   TRENDS IN MOLECULAR MEDICINE

Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

(2015) Agnieszka K. Witkiewicz et al.   Nature Communications

CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer

(2014) Edmond Chipumuro et al.   CELL

Targeting transcription regulation in cancer with a covalent CDK7 inhibitor

(2014) Nicholas Kwiatkowski et al.   NATURE

Albumin-Bound Paclitaxel plus Gemcitabine in Pancreatic Cancer

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma

(2014) Joydeep Bhadury et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research

(2014) M. Hidalgo et al.   Cancer Discovery

Systemic Delivery of microRNA-34a for Cancer Stem Cell Therapy

(2013) Sanjun Shi et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers

(2013) Jakob Lovén et al.   CELL

Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes

(2013) Warren A. Whyte et al.   CELL

Super-Enhancers in the Control of Cell Identity and Disease

(2013) Denes Hnisz et al.   CELL

The Epidemiology of Pancreatitis and Pancreatic Cancer

(2013) Dhiraj Yadav et al.   GASTROENTEROLOGY

EGFR Antagonists in Cancer Treatment

(2008) Fortunato Ciardiello et al.   NEW ENGLAND JOURNAL OF MEDICINE